Health Canada Issues Guidance on Off-Label Uses of Drugs in Trials

Drug Industry Daily
A A
Health Canada released new guidance that the agency hopes will make it easier to study the off-label benefits of drugs in clinical trials.

To View This Article:

Login

Subscribe To Drug Industry Daily